Ildr2em5099Tac
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Ildr2em5099Tac |
| Name: |
immunoglobulin-like domain containing receptor 2; endonuclease-mediated mutation 5099, Taconic |
| MGI ID: |
MGI:7639946 |
| Gene: |
Ildr2 Location: Chr1:166081708-166144392 bp, + strand Genetic Position: Chr1, 73.61 cM
|
| Alliance: |
Ildr2em5099Tac page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Null/knockout) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: CRISPR/Cas9 technology deleted a 17.8 kb genomic region containing exons 1 and 2 (including the putative promoter region). The position of the cutting sites was 1.7 kb upstream of exon 1 and 0.6 kb downstream of exon 2.
(J:347379)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ildr2 Mutation: |
28 strains or lines available
|
|
| Original: |
J:347379 Huetter J, et al., Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunol Res. 2020 Jul;8(7):895-911 |
| All: |
1 reference(s) |
|